Lucas Svetlana bought SCTX
July 23, 2026 · Form 4 insider transaction
Lucas Svetlana bought 109,426 shares of Scribe Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
109,426
Price
$0.00
Total value
N/A
InsiderLucas Svetlana
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 23, 2026
Filing dateJuly 27, 2026
Shares owned after109,426
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options will vest as to 1/48 of the total shares monthly over four years, with the first tranche scheduled to vest on August 23, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.